These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32968234)

  • 1. Acquired genetic changes in human pluripotent stem cells: origins and consequences.
    Halliwell J; Barbaric I; Andrews PW
    Nat Rev Mol Cell Biol; 2020 Dec; 21(12):715-728. PubMed ID: 32968234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitness selection in human pluripotent stem cells and interspecies chimeras: Implications for human development and regenerative medicine.
    Wu J; Barbaric I
    Dev Biol; 2021 Aug; 476():209-217. PubMed ID: 33891964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random Mutagenesis, Clonal Events, and Embryonic or Somatic Origin Determine the mtDNA Variant Type and Load in Human Pluripotent Stem Cells.
    Zambelli F; Mertens J; Dziedzicka D; Sterckx J; Markouli C; Keller A; Tropel P; Jung L; Viville S; Van de Velde H; Geens M; Seneca S; Sermon K; Spits C
    Stem Cell Reports; 2018 Jul; 11(1):102-114. PubMed ID: 29910126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell heterogeneity in human pluripotent stem cells.
    Yang S; Cho Y; Jang J
    BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of p53 in pluripotent stem cells.
    Fu X; Wu S; Li B; Xu Y; Liu J
    Protein Cell; 2020 Jan; 11(1):71-78. PubMed ID: 31691903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of hematopoietic cells derived from pluripotent stem cells.
    Bouhassira EE
    Expert Opin Biol Ther; 2013 Aug; 13(8):1099-102. PubMed ID: 23611514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets.
    Tan HL; Choo A
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of PTH-Expressing Cells From Human Pluripotent Stem Cells.
    Lawton BR; Martineau C; Sosa JA; Roman S; Gibson CE; Levine MA; Krause DS
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32810225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in culture and manipulation of human pluripotent stem cells.
    Qian X; Villa-Diaz LG; Krebsbach PH
    J Dent Res; 2013 Nov; 92(11):956-62. PubMed ID: 23934156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History and current status of clinical studies using human pluripotent stem cells.
    Kobold S; Bultjer N; Stacey G; Mueller SC; Kurtz A; Mah N
    Stem Cell Reports; 2023 Aug; 18(8):1592-1598. PubMed ID: 37028422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
    Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
    Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation.
    Núñez-Toldrà R; Martínez-Sarrà E; Gil-Recio C; Carrasco MÁ; Al Madhoun A; Montori S; Atari M
    BMC Cell Biol; 2017 Apr; 18(1):21. PubMed ID: 28427322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells.
    Heo HR; Song H; Kim HR; Lee JE; Chung YG; Kim WJ; Yang SR; Kim KS; Chun T; Lee DR; Hong SH
    Cell Death Dis; 2018 Oct; 9(11):1090. PubMed ID: 30356076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of genomic stability maintenancein pluripotent stem cells.
    Zheng P
    Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(6):858-863. PubMed ID: 35713312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.
    Lee J; Dykstra B; Sackstein R; Rossi DJ
    Curr Opin Hematol; 2015 Jul; 22(4):317-23. PubMed ID: 26049752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent Stem Cell Heterogeneity.
    Hayashi Y; Ohnuma K; Furue MK
    Adv Exp Med Biol; 2019; 1123():71-94. PubMed ID: 31016596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
    Keller A; Spits C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.